ReviewDiagnostics (Basel, Switzerland)2025

Diagnostics, Efficacy, and Safety of Immunomodulatory and Anti-Fibrotic Treatment for Interstitial Lung Disease Associated with Systemic Scleroderma (SSc-ILD).

Dawid Piecuch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.